SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling

Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) accounts for 0.05–2% of all RCCs. The majority of patients have germline mutations, most frequently in the SDHB gene. People with these mutations are predisposed to developing paragangliomas, phaeochromocytomas and gastrointestinal s...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the Royal College of Surgeons of England Vol. 103; no. 1; pp. e20 - e22
Main Authors Wilczek, Y, Sachdeva, A, Turner, H, Veeratterapillay, R
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.01.2021
Royal College of Surgeons
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) accounts for 0.05–2% of all RCCs. The majority of patients have germline mutations, most frequently in the SDHB gene. People with these mutations are predisposed to developing paragangliomas, phaeochromocytomas and gastrointestinal stromal tumours. Patients should be referred to genetic services for further workup and close surveillance imaging due to the risk of development of further tumours. We present a woman with SDH-deficient RCC and review the literature associated with this uncommon entity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Review-5
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0035-8843
1478-7083
1478-7083
DOI:10.1308/rcsann.2020.0196